M
Myovant Sciences
Women’s health and endocrine diseases medicines. Subsidiary of Roivant
About Myovant Sciences
Myovant Sciences is a biopharmaceutical company dedicated to redefining care for women and men through purpose-driven science, empowering medicines, and transformative advocacy. The company focuses on developing innovative treatments for uterine fibroids, endometriosis, and prostate cancer, aiming to improve the lives of millions affected by these conditions. Myovant operates in the healthcare market, primarily serving patients and healthcare providers. Its business model revolves around the research, development, and commercialization of novel therapies. Revenue is generated through the sale of these medicines, as well as potential partnerships and collaborations with other pharmaceutical companies. Myovant's pipeline includes promising drug candidates that address significant unmet medical needs, positioning the company as a key player in the biopharmaceutical industry.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2016
- Headquarters
- Brisbane, United States
- Listing
- IPO 2016
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
NovaQuest Capital Management
Hercules Capital
Dainippon Sumitomo Pharma
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
26 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Myovant Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Myovant Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.